Reuters logo
BRIEF-Shanghai Fosun Pharmaceutical's H1 net profit up, units to buy assets and products
August 29, 2017 / 12:08 PM / 21 days ago

BRIEF-Shanghai Fosun Pharmaceutical's H1 net profit up, units to buy assets and products

Aug 29 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd

* Says H1 net profit up 12.6 percent y/y at 1.7 billion yuan ($257.85 million)

* Says unit plans to buy Sinomedcare for 266.5 million yuan

* Says U.S. unit plans to buy U.S. Sandoz’s medicine products for $18 million

Source text in Chinese: bit.ly/2wOSdxU; bit.ly/2gmiwEL; bit.ly/2vFWv5S

Further company coverage: ($1 = 6.5930 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below